CA2451969A1 - Procede de solubilisation, de purification et de repliement de proteines - Google Patents

Procede de solubilisation, de purification et de repliement de proteines Download PDF

Info

Publication number: CA2451969A1
Authority: CA; Canada
Prior art keywords: amino acid; polypeptide; tfpi; urea; full length
Prior art date: 1995-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002451969A

Other languages

English (en)

Inventor

Glenn J. Dorin

Bo H. Arve

Gregory L. Pattison

Robert F. Hallenbeck

Kirk Johnson

Bao-Lu Chen

Rajsharan K. Rana

Maninder S. Hora

Hussan Madani

Mark E. Gustafson

Michael Tsang

Gary S. Bild

Gary V. Johnson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis Vaccines and Diagnostics Inc

GD Searle LLC

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-07

Publication date

1996-12-19

1996-06-07 Application filed by Individual filed Critical Individual

1996-06-07 Priority claimed from CA002223745A external-priority patent/CA2223745C/fr

1996-12-19 Publication of CA2451969A1 publication Critical patent/CA2451969A1/fr

Status Abandoned legal-status Critical Current

Links

102100030951 Tissue factor pathway inhibitor Human genes 0.000 title claims abstract description 292
108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 title claims abstract description 286
238000000034 method Methods 0.000 title claims abstract description 168
229920000642 polymer Polymers 0.000 claims abstract description 94
238000002360 preparation method Methods 0.000 claims abstract description 63
239000000203 mixture Substances 0.000 claims abstract description 41
238000000746 purification Methods 0.000 claims abstract description 19
229920000831 ionic polymer Polymers 0.000 claims abstract description 16
238000005063 solubilization Methods 0.000 claims abstract description 5
230000007928 solubilization Effects 0.000 claims abstract description 5
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 181
239000004202 carbamide Substances 0.000 claims description 104
108090000765 processed proteins & peptides Proteins 0.000 claims description 97
229920001184 polypeptide Polymers 0.000 claims description 94
102000004196 processed proteins & peptides Human genes 0.000 claims description 94
125000003275 alpha amino acid group Chemical group 0.000 claims description 69
239000011347 resin Substances 0.000 claims description 59
229920005989 resin Polymers 0.000 claims description 59
235000001014 amino acid Nutrition 0.000 claims description 54
239000000243 solution Substances 0.000 claims description 50
229920000388 Polyphosphate Polymers 0.000 claims description 48
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 48
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 48
239000001205 polyphosphate Substances 0.000 claims description 48
235000011176 polyphosphates Nutrition 0.000 claims description 48
239000000872 buffer Substances 0.000 claims description 40
239000007983 Tris buffer Substances 0.000 claims description 37
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 36
150000001413 amino acids Chemical class 0.000 claims description 34
210000003000 inclusion body Anatomy 0.000 claims description 33
239000012149 elution buffer Substances 0.000 claims description 26
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 25
101000653189 Homo sapiens Tissue factor pathway inhibitor Proteins 0.000 claims description 24
229920002684 Sepharose Polymers 0.000 claims description 24
235000004279 alanine Nutrition 0.000 claims description 24
239000011780 sodium chloride Substances 0.000 claims description 24
241000588724 Escherichia coli Species 0.000 claims description 23
239000011534 wash buffer Substances 0.000 claims description 20
238000006467 substitution reaction Methods 0.000 claims description 18
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 17
229910052921 ammonium sulfate Inorganic materials 0.000 claims description 17
235000011130 ammonium sulphate Nutrition 0.000 claims description 17
239000002202 Polyethylene glycol Substances 0.000 claims description 16
229920001223 polyethylene glycol Polymers 0.000 claims description 16
238000005406 washing Methods 0.000 claims description 16
229920002873 Polyethylenimine Polymers 0.000 claims description 15
150000003839 salts Chemical class 0.000 claims description 15
239000000356 contaminant Substances 0.000 claims description 14
239000001488 sodium phosphate Substances 0.000 claims description 14
229910000162 sodium phosphate Inorganic materials 0.000 claims description 14
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 14
150000001875 compounds Chemical class 0.000 claims description 12
230000001580 bacterial effect Effects 0.000 claims description 11
238000005277 cation exchange chromatography Methods 0.000 claims description 8
239000012539 chromatography resin Substances 0.000 claims description 8
238000001914 filtration Methods 0.000 claims description 8
235000017281 sodium acetate Nutrition 0.000 claims description 8
229920006317 cationic polymer Polymers 0.000 claims description 7
239000002244 precipitate Substances 0.000 claims description 6
239000001632 sodium acetate Substances 0.000 claims description 6
238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 5
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
239000007995 HEPES buffer Substances 0.000 claims description 4
239000003957 anion exchange resin Substances 0.000 claims description 4
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 4
239000012540 ion exchange chromatography resin Substances 0.000 claims description 4
241000894006 Bacteria Species 0.000 claims description 3
238000005571 anion exchange chromatography Methods 0.000 claims description 3
229920000447 polyanionic polymer Polymers 0.000 claims description 3
238000005349 anion exchange Methods 0.000 claims description 2
238000005119 centrifugation Methods 0.000 claims description 2
238000007865 diluting Methods 0.000 claims description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 2
PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims description 2
125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
230000003247 decreasing effect Effects 0.000 claims 2
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
239000008001 CAPS buffer Substances 0.000 claims 1
239000003729 cation exchange resin Substances 0.000 claims 1
239000012508 resin bead Substances 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 abstract description 132
102000004169 proteins and genes Human genes 0.000 abstract description 132
238000009472 formulation Methods 0.000 abstract description 8
235000018102 proteins Nutrition 0.000 description 124
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
239000011734 sodium Substances 0.000 description 24
229940024606 amino acid Drugs 0.000 description 21
229960002897 heparin Drugs 0.000 description 21
229920000669 heparin Polymers 0.000 description 21
230000003993 interaction Effects 0.000 description 20
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 19
-1 isocitrate ion Chemical class 0.000 description 19
239000002904 solvent Substances 0.000 description 19
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 18
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 17
230000008569 process Effects 0.000 description 17
238000002835 absorbance Methods 0.000 description 16
238000011068 loading method Methods 0.000 description 16
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 16
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
238000003556 assay Methods 0.000 description 15
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 15
239000012064 sodium phosphate buffer Substances 0.000 description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 14
229910019142 PO4 Inorganic materials 0.000 description 14
239000002253 acid Substances 0.000 description 14
229960000633 dextran sulfate Drugs 0.000 description 14
239000010452 phosphate Substances 0.000 description 14
229920001282 polysaccharide Polymers 0.000 description 14
239000005017 polysaccharide Substances 0.000 description 14
239000011324 bead Substances 0.000 description 13
210000004027 cell Anatomy 0.000 description 13
230000000694 effects Effects 0.000 description 13
230000014509 gene expression Effects 0.000 description 13
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
238000010828 elution Methods 0.000 description 12
150000004804 polysaccharides Chemical class 0.000 description 12
238000000108 ultra-filtration Methods 0.000 description 12
108010094028 Prothrombin Proteins 0.000 description 11
102100027378 Prothrombin Human genes 0.000 description 11
229930006000 Sucrose Natural products 0.000 description 11
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 11
229940039716 prothrombin Drugs 0.000 description 11
239000005720 sucrose Substances 0.000 description 11
229920002307 Dextran Polymers 0.000 description 10
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
229920002565 Polyethylene Glycol 400 Polymers 0.000 description 10
238000004128 high performance liquid chromatography Methods 0.000 description 10
102000055046 tissue-factor-pathway inhibitor 2 Human genes 0.000 description 10
108010016054 tissue-factor-pathway inhibitor 2 Proteins 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
235000018417 cysteine Nutrition 0.000 description 9
238000002156 mixing Methods 0.000 description 9
239000012614 Q-Sepharose Substances 0.000 description 8
230000002776 aggregation Effects 0.000 description 8
238000004220 aggregation Methods 0.000 description 8
239000012141 concentrate Substances 0.000 description 8
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 8
229960002086 dextran Drugs 0.000 description 8
238000000502 dialysis Methods 0.000 description 8
230000002209 hydrophobic effect Effects 0.000 description 8
230000004807 localization Effects 0.000 description 8
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 8
239000000047 product Substances 0.000 description 8
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 8
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 7
229930195725 Mannitol Natural products 0.000 description 7
108091005804 Peptidases Proteins 0.000 description 7
239000004365 Protease Substances 0.000 description 7
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 7
108010000499 Thromboplastin Proteins 0.000 description 7
102000002262 Thromboplastin Human genes 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
239000000594 mannitol Substances 0.000 description 7
235000010355 mannitol Nutrition 0.000 description 7
229920000053 polysorbate 80 Polymers 0.000 description 7
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
101710139626 Tissue factor pathway inhibitor Proteins 0.000 description 6
229960000583 acetic acid Drugs 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
239000000543 intermediate Substances 0.000 description 6
239000012528 membrane Substances 0.000 description 6
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 6
229940068968 polysorbate 80 Drugs 0.000 description 6
238000011084 recovery Methods 0.000 description 6
108020004414 DNA Proteins 0.000 description 5
108010074860 Factor Xa Proteins 0.000 description 5
239000004471 Glycine Substances 0.000 description 5
229930195714 L-glutamate Natural products 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
238000013019 agitation Methods 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
230000008901 benefit Effects 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
238000005345 coagulation Methods 0.000 description 5
230000015271 coagulation Effects 0.000 description 5
238000004090 dissolution Methods 0.000 description 5
238000009826 distribution Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
239000002002 slurry Substances 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
229920002683 Glycosaminoglycan Polymers 0.000 description 4
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
239000004698 Polyethylene Substances 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 4
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
150000001793 charged compounds Chemical class 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
239000000178 monomer Substances 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
230000037361 pathway Effects 0.000 description 4
230000002572 peristaltic effect Effects 0.000 description 4
229920001308 poly(aminoacid) Polymers 0.000 description 4
229920000573 polyethylene Polymers 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
238000000926 separation method Methods 0.000 description 4
238000002741 site-directed mutagenesis Methods 0.000 description 4
238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 4
239000011550 stock solution Substances 0.000 description 4
229960000187 tissue plasminogen activator Drugs 0.000 description 4
239000004475 Arginine Substances 0.000 description 3
101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 3
206010053567 Coagulopathies Diseases 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
239000004201 L-cysteine Substances 0.000 description 3
235000013878 L-cysteine Nutrition 0.000 description 3
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
235000009697 arginine Nutrition 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
238000005341 cation exchange Methods 0.000 description 3
125000003636 chemical group Chemical group 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000010367 cloning Methods 0.000 description 3
230000035602 clotting Effects 0.000 description 3
229960003067 cystine Drugs 0.000 description 3
238000011026 diafiltration Methods 0.000 description 3
239000000499 gel Substances 0.000 description 3
239000012362 glacial acetic acid Substances 0.000 description 3
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
238000012545 processing Methods 0.000 description 3
239000008213 purified water Substances 0.000 description 3
238000012216 screening Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000003381 solubilizing effect Effects 0.000 description 3
238000007614 solvation Methods 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
238000011282 treatment Methods 0.000 description 3
108020005087 unfolded proteins Proteins 0.000 description 3
210000005253 yeast cell Anatomy 0.000 description 3
BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
108010054265 Factor VIIa Proteins 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
101000635804 Homo sapiens Tissue factor Proteins 0.000 description 2
241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
229920002274 Nalgene Polymers 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000003024 amidolytic effect Effects 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
230000003872 anastomosis Effects 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
239000001110 calcium chloride Substances 0.000 description 2
235000011148 calcium chloride Nutrition 0.000 description 2
229910001628 calcium chloride Inorganic materials 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000006555 catalytic reaction Methods 0.000 description 2
239000006143 cell culture medium Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
238000013375 chromatographic separation Methods 0.000 description 2
238000010668 complexation reaction Methods 0.000 description 2
239000006184 cosolvent Substances 0.000 description 2
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
229940012414 factor viia Drugs 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000012634 fragment Substances 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
229960004198 guanidine Drugs 0.000 description 2
229960000789 guanidine hydrochloride Drugs 0.000 description 2
206010073071 hepatocellular carcinoma Diseases 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
238000004255 ion exchange chromatography Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
230000000873 masking effect Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000002609 medium Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
238000006386 neutralization reaction Methods 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
238000012856 packing Methods 0.000 description 2
229940085991 phosphate ion Drugs 0.000 description 2
229920000724 poly(L-arginine) polymer Polymers 0.000 description 2
229920000768 polyamine Polymers 0.000 description 2
229920002704 polyhistidine Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
238000011176 pooling Methods 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
230000012846 protein folding Effects 0.000 description 2
239000012460 protein solution Substances 0.000 description 2
238000005086 pumping Methods 0.000 description 2
238000009790 rate-determining step (RDS) Methods 0.000 description 2
238000004153 renaturation Methods 0.000 description 2
239000012465 retentate Substances 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
239000010703 silicon Substances 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
229940087562 sodium acetate trihydrate Drugs 0.000 description 2
235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
101150070659 tfpI gene Proteins 0.000 description 2
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
239000003643 water by type Substances 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
241000182988 Assa Species 0.000 description 1
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical group C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
244000309456 Decussocarpus nagi Species 0.000 description 1
235000008375 Decussocarpus nagi Nutrition 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
108010053070 Glutathione Disulfide Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
229920001499 Heparinoid Polymers 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
229930064664 L-arginine Natural products 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
108010020346 Polyglutamic Acid Proteins 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
108091006629 SLC13A2 Proteins 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
206010040070 Septic Shock Diseases 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
108010055141 Tifacogin Proteins 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
125000005210 alkyl ammonium group Chemical group 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
238000010171 animal model Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000013011 aqueous formulation Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
108010006025 bovine growth hormone Proteins 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000005779 cell damage Effects 0.000 description 1
208000037887 cell injury Diseases 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000007819 clotting time assay Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000011109 contamination Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000000368 destabilizing effect Effects 0.000 description 1
239000012538 diafiltration buffer Substances 0.000 description 1
125000005131 dialkylammonium group Chemical group 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
230000001516 effect on protein Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000002554 heparinoid Substances 0.000 description 1
229940025770 heparinoids Drugs 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
230000014508 negative regulation of coagulation Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000001151 other effect Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
239000005365 phosphate glass Substances 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
108010011110 polyarginine Proteins 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
238000011112 process operation Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
238000011403 purification operation Methods 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
239000006176 redox buffer Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000010850 salt effect Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000036303 septic shock Effects 0.000 description 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
238000009987 spinning Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
238000011191 terminal modification Methods 0.000 description 1
UDEJEOLNSNYQSX-UHFFFAOYSA-J tetrasodium;2,4,6,8-tetraoxido-1,3,5,7,2$l^{5},4$l^{5},6$l^{5},8$l^{5}-tetraoxatetraphosphocane 2,4,6,8-tetraoxide Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)O1 UDEJEOLNSNYQSX-UHFFFAOYSA-J 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1
230000007704 transition Effects 0.000 description 1
125000005208 trialkylammonium group Chemical group 0.000 description 1

Landscapes

Peptides Or Proteins (AREA)

CA002451969A 1995-06-07 1996-06-07 Procede de solubilisation, de purification et de repliement de proteines Abandoned CA2451969A1 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US47366895A	1995-06-07	1995-06-07
US47767795A	1995-06-07	1995-06-07
US08/477,677		1995-06-07
US08/473,668		1995-06-07
CA002223745A CA2223745C (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002223745A Division CA2223745C (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines

Publications (1)

Publication Number	Publication Date
CA2451969A1 true CA2451969A1 (fr)	1996-12-19

Family

ID=31191505

Family Applications (8)

Application Number	Title	Priority Date	Filing Date
CA002450804A Abandoned CA2450804A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002450800A Abandoned CA2450800A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002451969A Abandoned CA2451969A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002451970A Abandoned CA2451970A1 (fr)	1995-06-07	1996-06-07	Methode d'aide au repli de la proteine tfpi
CA002450797A Abandoned CA2450797A1 (fr)	1995-06-07	1996-06-07	Methode de solubilisation de proteines comportant deux domaines a charges opposees
CA002451973A Abandoned CA2451973A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002450953A Abandoned CA2450953A1 (fr)	1995-06-07	1996-06-07	Procede de sobulisation, de purification et de repliement de proteines
CA002450795A Abandoned CA2450795A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
CA002450804A Abandoned CA2450804A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002450800A Abandoned CA2450800A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines

Family Applications After (5)

Application Number	Title	Priority Date	Filing Date
CA002451970A Abandoned CA2451970A1 (fr)	1995-06-07	1996-06-07	Methode d'aide au repli de la proteine tfpi
CA002450797A Abandoned CA2450797A1 (fr)	1995-06-07	1996-06-07	Methode de solubilisation de proteines comportant deux domaines a charges opposees
CA002451973A Abandoned CA2451973A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines
CA002450953A Abandoned CA2450953A1 (fr)	1995-06-07	1996-06-07	Procede de sobulisation, de purification et de repliement de proteines
CA002450795A Abandoned CA2450795A1 (fr)	1995-06-07	1996-06-07	Procede de solubilisation, de purification et de repliement de proteines

Country Status (1)

Country	Link
CA (8)	CA2450804A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN121587349B (zh) *	2026-01-28	2026-06-09	内蒙古蒙牛乳业（集团）股份有限公司	高浓度无菌乳铁蛋白液及其制备方法

1996
- 1996-06-07 CA CA002450804A patent/CA2450804A1/fr not_active Abandoned
- 1996-06-07 CA CA002450800A patent/CA2450800A1/fr not_active Abandoned
- 1996-06-07 CA CA002451969A patent/CA2451969A1/fr not_active Abandoned
- 1996-06-07 CA CA002451970A patent/CA2451970A1/fr not_active Abandoned
- 1996-06-07 CA CA002450797A patent/CA2450797A1/fr not_active Abandoned
- 1996-06-07 CA CA002451973A patent/CA2451973A1/fr not_active Abandoned
- 1996-06-07 CA CA002450953A patent/CA2450953A1/fr not_active Abandoned
- 1996-06-07 CA CA002450795A patent/CA2450795A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
CA2451970A1 (fr)	1996-12-19
CA2450795A1 (fr)	1996-12-19
CA2450953A1 (fr)	1996-12-19
CA2450800A1 (fr)	1996-12-19
CA2450804A1 (fr)	1996-12-19
CA2451973A1 (fr)	1996-12-19
CA2450797A1 (fr)	1996-12-19

Legal Events

Date	Code	Title	Description
2003-12-19	EEER	Examination request
2011-03-10	FZDE	Dead

Publication	Publication Date	Title
CA2223745C (fr)	2004-03-16	Procede de solubilisation, de purification et de repliement de proteines
Randolph et al.	2002	Surfactant-protein interactions
EP0376251B1 (fr)	1995-04-12	Une nouvelle glycoprotéine de type thrombomoduline susceptible d'être obtenue à partir de l'urine
US5888968A (en)	1999-03-30	TFPI formulation
JP4233114B2 (ja)	2009-03-04	フォン・ブィレブランド因子の治療用フラグメント
AU713338B2 (en)	1999-12-02	Method of solubilizing, purifying, and refolding protein
AU759412B2 (en)	2003-04-17	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
AU2003200506B2 (en)	2007-01-18	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
AU713338C (en)	2000-09-28	Method of solubilizing, purifying, and refolding protein
CA2450953A1 (fr)	1996-12-19	Procede de sobulisation, de purification et de repliement de proteines
WO1992014832A1 (fr)	1992-09-03	Procedes pour la purification de fdlb humains
AU2006275800A1 (en)	2007-02-08	Method and system for in vitro protein folding
JPH04279598A (ja)	1992-10-05	血清カルシウム降下因子
Hovgaard et al.	3	Protein purification
JPH08259595A (ja)	1996-10-08	血小板抗凝集剤、血栓形成予防剤及び止血剤
MXPA01002206A (en)	2002-06-05	Stabilized granulocyte colony stimulating factor